Valo Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
9
Valo Therapeutics General Information
Description
Developer of immunotherapy treatments designed to improve cancer treatment and prevention. The company develops a peptide-based immunotherapy platform that combines oncolytic and non-replicating viral vectors with disease-specific peptides to stimulate targeted immune responses, enabling the development of adaptable cancer therapies with improved specificity and immunogenicity.
Contact Information
Website
www.valotx.comCorporate Office
- Viikinkaari 6
- 00790 Helsinki
- Finland
Corporate Office
- Viikinkaari 6
- 00790 Helsinki
- Finland
Valo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 10-Mar-2025 | $20M | Completed | Clinical Trials - Phase 2 | ||
| 7. Later Stage VC | 15-Nov-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 05-Mar-2021 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A) | 06-Feb-2020 | Cancelled | Pre-Clinical Trials | |||
| 4. Early Stage VC | 06-Feb-2020 | Completed | Pre-Clinical Trials | |||
| 3. Debt - General | 04-Jul-2017 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 31-Jan-2017 | $4.91M | $4.91M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2016 | Completed | Startup |
Valo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Valo Therapeutics Patents
Valo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202407048-D0 | Cancer therapy | Inactive | 17-May-2024 | ||
| JP-2023543554-A | Modified mycobacterium bovis vaccine | Active | 03-Sep-2020 | ||
| JP-7924955-B2 | Modified mycobacterium bovis vaccine | Active | 03-Sep-2020 | ||
| AU-2021336066-A1 | Modified mycobacterium bovis vaccines | Active | 03-Sep-2020 | ||
| AU-2021336066-B2 | Modified mycobacterium bovis vaccines | Active | 03-Sep-2020 | A61P35/00 |
Valo Therapeutics Signals
Valo Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDP Venture Capital (Rome) | Venture Capital | Minority | ||
| Indaco Venture Partners | Venture Capital | Minority | ||
| Tech and Biomedical Foundation | Venture Capital | Minority | ||
| UNDERWOOD CAPITAL | Asset Manager | Minority | ||
| Angel (individual) | Minority |
Valo Therapeutics FAQs
-
When was Valo Therapeutics founded?
Valo Therapeutics was founded in 2016.
-
Where is Valo Therapeutics headquartered?
Valo Therapeutics is headquartered in Helsinki, Finland.
-
What is the size of Valo Therapeutics?
Valo Therapeutics has 16 total employees.
-
What industry is Valo Therapeutics in?
Valo Therapeutics’s primary industry is Drug Discovery.
-
Is Valo Therapeutics a private or public company?
Valo Therapeutics is a Private company.
-
What is Valo Therapeutics’s current revenue?
The current revenue for Valo Therapeutics is .
-
How much funding has Valo Therapeutics raised over time?
Valo Therapeutics has raised $44.7M.
-
Who are Valo Therapeutics’s investors?
CDP Venture Capital (Rome), Indaco Venture Partners, Tech and Biomedical Foundation, UNDERWOOD CAPITAL, and are 5 of 9 investors who have invested in Valo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process